The funding will be spread over four years, with BXLS also eligible for regulatory and commercial milestones, plus royalties on worldwide sales
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
Expansion at the Oss (NL) site adds capacity and R&D capabilities, supporting the development and manufacturing of ADCs and other novel bioconjugates from First-in-Human to commercialization
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
Waskyra is an ex vivo gene therapy that uses patients’ own CD34+ hematopoietic stem and progenitor cells, genetically engineered with a lentiviral vector
Favorable outcome would contribute to significantly containing the Roundup litigation as the company continues its multi-pronged strategy
Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
